RxDoctor Payments DataLook up a doctor →

Christi Dieterich, NP

Gerontology · Elkridge, MDNPI 1184873895

Payments from drug & device makers

$14,976in general payments, 2019–2025

Across 668 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • GSK$1K
  • Amgen$1K
  • Pfizer$884
  • Novo Nordisk$787
  • plus $8K from 51 others

What the payments were for

  • Food & beverage$14,65498%
  • Education$3222%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie115$1,774
AstraZeneca(2 entities)38$1,483
GSK52$1,242
Amgen(2 entities)44$1,080
Pfizer39$884
Novo Nordisk40$787
Astellas Pharma US Inc25$714
Otsuka America Pharmaceutical, Inc.24$660
Lilly USA, LLC27$517
Bayer20$429
Sumitomo Pharma America, Inc.18$417
Phathom Pharmaceuticals, Inc.19$356
Biohaven Pharmaceutical Holding Company Ltd.10$306
Corcept Therapeutics14$295
Boehringer Ingelheim15$282
Lundbeck LLC16$263
Biohaven Pharmaceuticals, Inc.9$260
Harmony Biosciences LLC5$227
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC12$225
Corium, LLC5$208
Novartis10$201
Abbott10$197
Esperion Therapeutics, Inc.7$152
Axsome Therapeutics, Inc.6$147
Acadia Pharmaceuticals Inc6$137
Amarin Pharma, Inc.7$136
Urovant Sciences Inc2$125
Kowa Pharmaceuticals America, Inc.7$123
Biogen5$123
Merck5$120
Sunovion Pharmaceuticals Inc.6$111
Verona Pharma, Inc.4$97
Amneal Pharmaceuticals LLC5$80
Teva Pharmaceuticals USA, Inc.3$60
Mylan Specialty L.p.3$57
Nevro Corp.3$57
Takeda Pharmaceuticals U.S.A., Inc.2$49
Xeris Pharmaceuticals, Inc.3$48
Genentech USA, Inc.2$45
Shield Therapeutics Inc2$45
Avanir Pharmaceuticals, Inc.3$43
Idorsia Pharmaceuticals US Inc2$42
Organogenesis Inc.1$42
Eisai Inc.2$37
Vanda Pharmaceuticals Inc.1$35
TMS Neurohealth Centers Inc.2$32
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$31
Inspire Medical Systems, Inc.1$29
Ironwood Pharmaceuticals, Inc2$23
Viatris Specialty LLC1$22
Jazz Pharmaceuticals Inc.1$21
Sun Pharmaceutical Industries Inc.1$21
Dexcom, Inc.1$20
Currax Pharmaceuticals LLC1$17
Indivior Inc.1$14
Kaleo, Inc.1$14
Otsuka Pharmaceutical Development & Commercialization, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,976 in reported general payments places this provider in the 95th percentile of 108 gerontology providers in Maryland.

See all gerontology providers in Maryland

Medicare billing

Part B allowed, 2024
$170,931
Medicare patients
409
Services billed
2,407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NuplazidPimavanserin Tartrate14$72,198
EliquisApixaban97$64,151
MounjaroTirzepatide20$29,636
XareltoRivaroxaban39$24,373
RexultiBrexpiprazole17$24,271
OzempicSemaglutide21$23,817
JardianceEmpagliflozin26$23,670
FarxigaDapagliflozin Propanediol41$19,314
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$18,357
GemtesaVibegron24$16,425
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$15,295
VraylarCariprazine Hcl11$14,697
JanuviaSitagliptin Phosphate26$14,400
MyrbetriqMirabegron21$12,638
Memantine Hcl230$8,190

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Acadia Pharmaceuticals IncNuplazid$137$72,19814 claims
PfizerEliquis$884$64,15197 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,483$34,60963 claims
Lilly USA, LLCMounjaro$517$29,63620 claims
Otsuka America Pharmaceutical, Inc.Rexulti$660$24,27117 claims
Novo NordiskOzempic$787$23,81721 claims
Boehringer IngelheimJardiance$282$23,67026 claims
GSKTrelegy Ellipta$1,242$18,35721 claims
Sumitomo Pharma America, Inc.Gemtesa$417$16,42524 claims
AbbVieVraylar$1,774$14,69711 claims
MerckJanuvia$120$14,40026 claims
Astellas Pharma US IncMyrbetriq$714$12,63821 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 108 gerontology providers in Maryland.

Other gerontology in Elkridge

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →